rxstat › Drug prices › Ustekinumab
Ustekinumab (Wezlana, Steqeyma) price in Canada
No current shortage
Ustekinumab 45 mg/0.5ml solution costs about $2755.88 per billed unit (often a pen or vial) on public drug plan price lists across 3 provinces, before the pharmacy's dispensing fee.
Ustekinumab has no current shortage reported in Canada. No active reports are on file.
Price by province
| Strength and form | AB | SK | ON | NB | NS |
|---|---|---|---|---|---|
| 45 mg/0.5ml Solution | $2755.88/unit | $61.24/unit | $2755.88/unit | $2755.88/syringe | $2755.88/unit |
| 5 mg/ml Solution | $1248.00/unit | $9.60/unit | $1248.00/unit | $1248.00/vial | $48.00/unit |
| 90 mg/1ml Solution | $2755.88/unit | $30.62/unit | $2755.88/unit | $2755.88/syringe | $2755.88/unit |
| 90 mg/ml Solution | $2755.88/unit | $30.62/unit | $2755.88/unit | $2755.88/syringe | $2755.88/unit |
| Plan coverage | Covered | Special approval | Covered | Special approval | Special approval |
What you'll pay at the pharmacy
These are the prices public drug plans list for the drug itself. At the counter, pharmacies add a dispensing fee and in some provinces a markup, so paying cash costs more, and for cheap generics the fee is often more than the drug. If you have a public or private plan, your share depends on its deductible and co-pay.
Listed products by province
Alberta: 29 products
- Jamteki I.v. 5 mg/ml Solution · JPC
- Otulfi I.v. 5 mg/ml Solution · FKC
- Pyzchiva I.v. 5 mg/ml Solution · ORC
- Steqeyma Iv 5 mg/ml Solution · CHC
- Yesintek I.v. 5 mg/ml Solution · BBC
- Wezlana I.v. 5 mg/ml Solution · AMG
- Finlius I.v. 5 mg/ml Solution · JAI
- Stelara I.v. 5 mg/ml Solution · JAI
- Wezlana 45 mg/0.5ml Solution · AMG
- Wezlana 45 mg/0.5ml Solution · AMG
- Wezlana 45 mg/0.5ml Solution · AMG
- Wezlana 90 mg/1ml Solution · AMG
- Wezlana 90 mg/1ml Solution · AMG
- Steqeyma 45 mg/0.5ml Solution · CHC
- Steqeyma 90 mg/1ml Solution · CHC
- Jamteki 45 mg/0.5ml Solution · JPC
- Otulfi 45 mg/0.5ml Solution · FKC
- Pyzchiva 45 mg/0.5ml Solution · ORC
- Steqeyma 45 mg/0.5ml Solution · CHC
- Yesintek 45 mg/0.5ml Solution · BBC
- Jamteki 90 mg/1ml Solution · JPC
- Otulfi 90 mg/ml Solution · FKC
- Pyzchiva 90 mg/1ml Solution · ORC
- Steqeyma 90 mg/1ml Solution · CHC
- Yesintek 90 mg/ml Solution · BBC
- Finlius 45 mg/0.5ml Solution · JAI
- Finlius 90 mg/1ml Solution · JAI
- Stelara 45 mg/0.5ml Solution · JAI
- Stelara 90 mg/1ml Solution · JAI
Saskatchewan: 17 products
- Wezlana I.v. 5 mg/ml Solution · AMG
- Steqeyma Iv 5 mg/ml Solution · CEL
- Pyzchiva I.v. 5 mg/ml Solution · ORG
- Otulfi I.v. 5 mg/ml Solution · FCL
- Jamteki 90 mg/1ml Solution · JPC
- Wezlana 90 mg/1ml Solution · AMG
- Steqeyma 90 mg/1ml Solution · CEL
- Pyzchiva 90 mg/1ml Solution · ORG
- Otulfi 90 mg/ml Solution · FCL
- Wezlana 90 mg/1ml Solution · AMG
- Wezlana 45 mg/0.5ml Solution · AMG
- Wezlana 45 mg/0.5ml Solution · AMG
- Steqeyma 45 mg/0.5ml Solution · CEL
- Pyzchiva 45 mg/0.5ml Solution · ORG
- Otulfi 45 mg/0.5ml Solution · FCL
- Jamteki 45 mg/0.5ml Solution · JPC
- Wezlana 45 mg/0.5ml Solution · AMG
Ontario: 22 products
- Wezlana I.v. 5 mg/ml Solution · Amgen Canada Inc.
- Yesintek I.v. 5 mg/ml Solution · Biosimilar Collaborations Ireland Limited
- Pyzchiva I.v. 5 mg/ml Solution · Samsung Bioepis Co. Ltd
- Otulfi I.v. 5 mg/ml Solution · Fresenius Kabi Canada Ltd.
- Steqeyma Iv 5 mg/ml Solution · Celltrion Healthcare Co. Ltd.
- Jamteki I.v. 5 mg/ml Solution · Jamp Pharma Corporation
- Wezlana 45 mg/0.5ml Solution · Amgen Canada Inc.
- Pyzchiva 45 mg/0.5ml Solution · Samsung Bioepis Co. Ltd
- Jamteki 45 mg/0.5ml Solution · Jamp Pharma Corporation
- Wezlana 45 mg/0.5ml Solution · Amgen Canada Inc.
- Otulfi 45 mg/0.5ml Solution · Fresenius Kabi Canada Ltd.
- Yesintek 45 mg/0.5ml Solution · Biosimilar Collaborations Ireland Limited
- Wezlana 45 mg/0.5ml Solution · Amgen Canada Inc.
- Yesintek 90 mg/ml Solution · Biosimilar Collaborations Ireland Limited
- Otulfi 90 mg/ml Solution · Fresenius Kabi Canada Ltd.
- Wezlana 90 mg/1ml Solution · Amgen Canada Inc.
- Pyzchiva 90 mg/1ml Solution · Samsung Bioepis Co. Ltd
- Jamteki 90 mg/1ml Solution · Jamp Pharma Corporation
- Wezlana 90 mg/1ml Solution · Amgen Canada Inc.
- Steqeyma 45 mg/0.5ml Solution · Celltrion Healthcare Co. Ltd.
- Steqeyma 45 mg/0.5ml Solution · Celltrion Healthcare Co. Ltd.
- Steqeyma 90 mg/1ml Solution · Celltrion Healthcare Co. Ltd.
New Brunswick: 19 products
- Wezlana I.v. 5 mg/ml Solution · AGA
- Steqeyma Iv 5 mg/ml Solution · CLT
- Pyzchiva I.v. 5 mg/ml Solution · ORG
- Otulfi I.v. 5 mg/ml Solution · FKB
- Yesintek I.v. 5 mg/ml Solution · BIL
- Jamteki 90 mg/1ml Solution · JPC
- Wezlana 45 mg/0.5ml Solution · AGA
- Wezlana 90 mg/1ml Solution · AGA
- Wezlana 45 mg/0.5ml Solution · AGA
- Steqeyma 45 mg/0.5ml Solution · CLT
- Steqeyma 90 mg/1ml Solution · CLT
- Pyzchiva 45 mg/0.5ml Solution · ORG
- Pyzchiva 90 mg/1ml Solution · ORG
- Wezlana 90 mg/1ml Solution · AGA
- Wezlana 45 mg/0.5ml Solution · AGA
- Otulfi 45 mg/0.5ml Solution · FKB
- Otulfi 90 mg/ml Solution · FKB
- Yesintek 45 mg/0.5ml Solution · BIL
- Yesintek 90 mg/ml Solution · BIL
Nova Scotia: 24 products
- Wezlana I.v. 5 mg/ml Solution · AGA
- Steqeyma Iv 5 mg/ml Solution · CLT
- Pyzchiva I.v. 5 mg/ml Solution · ORG
- Otulfi I.v. 5 mg/ml Solution · FKB
- Yesintek I.v. 5 mg/ml Solution · BIL
- Jamteki 45 mg/0.5ml Solution · JPC
- Jamteki 90 mg/1ml Solution · JPC
- Wezlana 45 mg/0.5ml Solution · AGA
- Wezlana 90 mg/1ml Solution · AGA
- Wezlana 45 mg/0.5ml Solution · AGA
- Wezlana 90 mg/1ml Solution · AGA
- Wezlana 45 mg/0.5ml Solution · AGA
- Steqeyma 45 mg/0.5ml Solution · CLT
- Steqeyma 90 mg/1ml Solution · CLT
- Pyzchiva 45 mg/0.5ml Solution · ORG
- Pyzchiva 90 mg/1ml Solution · ORG
- Otulfi 45 mg/0.5ml Solution · FKB
- Otulfi 90 mg/ml Solution · FKB
- Steqeyma 45 mg/0.5ml Solution · CLT
- Yesintek 45 mg/0.5ml Solution · BIL
- Yesintek 90 mg/ml Solution · BIL
- Yesintek 45 mg/0.5ml Solution · BIL
- Stelara 45 mg/0.5ml Solution · JAN
- Stelara 90 mg/1ml Solution · JAN
Shortage status
No shortage or discontinuation reports have been filed with Health Canada for Ustekinumab. rxstat watches those reports through the day; sign up below to hear if that changes.
Common questions
How much does Ustekinumab cost in Canada?
Ustekinumab 45 mg/0.5ml solution costs about $2755.88 per billed unit (often a pen or vial) on public drug plan price lists across 3 provinces, before the pharmacy's dispensing fee.
Is Ustekinumab covered by provincial drug plans?
On the public plans' own lists: Alberta: covered; Saskatchewan: special approval; Ontario: covered; New Brunswick: special approval; Nova Scotia: special approval. "Special approval" means the plan covers it only for some patients, on a request from the prescriber. "Price list" means the province publishes its price but not its coverage.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Related drugs (immunosuppressants)
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.